Asarfi Hospital share price, P/E, ROE & financials

As of 6 Nov 2026, Asarfi Hospital trades at 20.7× trailing earnings, below the industry P/E of 47.7×, and the shares are 27% below their 52-week high. Its ROCE of 18% is the second-highest among the 7 largest Medical Care Facilities peers, and sales and net profit grew 35% and 28% a year over 3 years. Debt is 0.54× equity. It is listed on an SME platform with a market cap of ₹368 Cr, ranked 26th of 40 Medical Care Facilities companies by market cap; the shares rose 30% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹186.00
Day high: ₹190.00
Day low: ₹185.00
Prev. close: ₹186.00
Volume: 18K

Health check

4 good · 2 fair

ReturnsAhead
+29.7% over a year, better than 7 of 7 peers.
Price tagCheaper
P/E 20.7 vs industry 47.7.
GrowthStrong
Sales +34.5%, profit +27.6% a year over 3 years.
ProfitabilityAverage
ROCE 18.2% vs peer median 11.9%.
Balance sheetFair
Debt 0.54× equity, interest covered 6.6×, Piotroski 9 of 9.
Red flagsNone found
No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹368 Cr, #26 of 40 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹185 Cr · profit ₹18 Cr

Market cap: ₹368 Cr; Small cap
P/E: 20.7; Industry 47.7
Price to book: 3.61; Peers 8.06
Dividend yield: 0.00%
ROE: 19.1%; Peers 12.8%
ROCE: 18.2%; Peers 11.9%
Debt to equity: 0.54; Debt ₹55 Cr
EPS (TTM): ₹9.05
OPM (TTM): 19.7%; Net margin 9.6%
Sales growth: +33.2%; Latest quarter vs a year ago
Profit growth: +36.7%; Latest quarter vs a year ago
Price to sales: 1.99; EV/EBITDA 11.0

Strengths

Return on equity of 19.1%.
Quarterly profit up 36.7% on a year ago.
Quarterly sales up 33.2% on a year ago.
P/E of 20.7 against an industry P/E of 47.7.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Asarfi Hospital

Asarfi Hospital Limited operates a hospital under the Asarfi Hospital name in India. The company offers healthcare services that focus on prevention, diagnosis, treatment, and rehabilitation. Asarfi Hospital Limited was incorporated in 2005 and is based in Dhanbad, India.

Headquarters: Dhanbad
Sector: Healthcare
ISIN: INE0DN001027
Website: asarfi.in

Price range

52 weeks

₹143.00₹256.95

Today

₹185.00₹190.00

Avg volume (3M): 48.7K
1-year return: plus 29.7%
From 52-week high: minus 27.2%

Peers · Medical Care Facilities

Compare with peers Screen the whole industry

Company
APOLLOHOSPApollo Hospitals Enterprise	8,446.00	plus 0.90%	1,21,441	54.0	11.45	19.2%	22.5%	15.4%	14.8%	33.3%	0.24%	plus 7.2%
MAXHEALTHMax Healthcare Institute	934.00	plus 0.21%	90,909	66.1	8.03	12.6%	12.8%	26.8%	22.4%	9.3%	0.21%	minus 18.1%
MANIPALHOSManipal Health Enterprises	646.70	minus 1.61%	85,065	133.6	9.05	9.8%	9.2%	17.8%	–	–	0.00%	minus 3.0%
ASTERDMAster DM Quality Care	713.15	minus 0.89%	62,092	90.7	8.06	9.4%	9.7%	17.4%	15.7%	−3.0%	0.42%	plus 4.5%
FORTISFortis Healthcare	766.90	minus 6.45%	57,898	55.7	5.52	11.9%	10.4%	22.2%	13.3%	20.9%	0.13%	minus 19.6%
NHNarayana Hrudayalaya	1,903.00	minus 0.65%	38,650	44.7	7.73	11.4%	19.1%	18.5%	20.5%	9.9%	0.24%	plus 4.7%
MEDANTAGlobal Health	1,387.60	minus 0.15%	37,264	60.4	8.63	15.0%	15.2%	22.1%	17.2%	19.5%	0.04%	plus 11.2%
ASARFIAsarfi Hospital	187.00	plus 0.54%	368	20.7	3.61	18.2%	19.1%	19.7%	34.5%	27.6%	0.00%	plus 29.7%
Median of 7 peers	–	−0.65%	62,092	60.4	8.06	11.9%	12.8%	18.5%	16.5%	14.7%	0.21%	4.5%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
35.7	44.9	46.1	45.2	47.5
28.7	36	36	37.5	38.1
7	8.9	10.1	7.7	9.5
19.6%	19.8%	21.9%	17.1%	19.9%
1.4	0.8	1.5	0.6	0.6
1.2	1.1	1.3	0.7	1.2
3	2.9	2.9	2.8	3.1
4.2	5.7	7.4	4.9	5.7
25.6%	25.7%	27.2%	20.0%	25.2%
3.1	4.2	5.4	3.9	4.3
1.59	2.13	2.76	1.99	2.17

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +34.5%
Profit CAGR 3Y: +27.6%
EPS CAGR 3Y: +27.6%
ROE: 19.1%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
70.7	84.4	121	172
–	+19.4%	+43.1%	+42.6%
56.9	68.3	94.4	137
13.8	16.1	26.3	35.3
19.5%	19.0%	21.8%	20.5%
1.9	1.2	2.6	2.4
0.9	2.3	4	4
3.9	8.8	12.7	11.5
–	–	2.1	0
10.9	6.2	14.3	22.2
26.4%	33.3%	26.1%	24.9%
8	4.2	10.6	16.7
–	minus 48.1%	+154.1%	+57.5%
4.07	2.31	5.37	8.47

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
14.5	19.7	19.7	19.7
27.3	50.7	61.3	78
17.2	31.9	48.6	57.6
34.4	51.8	34.3	38
93.4	154	164	193
56.8	107	104	111
18.2	13.1	2.6	2.8
–	1	2.1	9.5
8.5	16.4	14.4	13.1
9.9	16.7	40.6	56.7
93.4	154	164	193

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
−2.1	26.1	−4.3	18.3
−13.6	−63.2	−7.4	−18.3
16.8	36.4	12.6	4.8
1.1	−0.7	0.8	4.8
−20.1	−46.1	−11.4	−18.1
−22.2	−20	−15.8	0.2

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you